Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Cholesterol in Precision Lipid Metabolism Research: Molecula
2026-07-18
Explore how cholesterol, the principal sterol, drives cutting-edge lipid metabolism research and membrane studies. This article uniquely dissects molecular parameters, protocol decisions, and translational implications, providing deeper guidance for researchers using high-purity cholesterol.
-
PDK4-IN-1 Hydrochloride: Selective Pyruvate Dehydrogenase Ki
2026-07-17
PDK4-IN-1 hydrochloride is a highly selective and orally active pyruvate dehydrogenase kinase 4 inhibitor. It directly activates the PDH complex and enhances mitochondrial energy metabolism. This product enables precise control of glycolysis and TCA cycle regulation for in vitro and in vivo metabolic research.
-
rhBNP Inhibits Renal Ferroptosis via Selenium Recycling in A
2026-07-17
This study reveals that recombinant human brain natriuretic peptide (rhBNP) mitigates renal ischemia-reperfusion injury by upregulating selenocysteine lyase (SCLY), thereby promoting selenium recycling and inhibiting ferroptosis. These findings introduce SCLY-mediated selenium metabolism as a novel therapeutic axis for acute kidney injury.
-
Comparative Metabolomics of Taihangia rupestris: Antioxidant
2026-07-16
This study systematically compares wild and cultivated Taihangia rupestris leaves using UPLC-MS/MS profiling integrated with multiple in vitro antioxidant and a-glucosidase inhibition assays. The research demonstrates that foothill-cultivated specimens not only match but outperform wild plants in bioactive compound abundance and dual bioactivity, highlighting the feasibility of sustainable cultivation for antidiabetic natural product development.
-
Ginsenoside Rg1: Precision Neuroimmune Modulation in Researc
2026-07-16
Explore the advanced mechanisms and translational potential of Ginsenoside Rg1, a leading triterpene saponin, for neuroprotection and neuroimmune pathway research. This article goes beyond assay basics to reveal practical innovations and experimental insights.
-
FerroOrange: Precise Fe²⁺ Fluorescent Probe for Live-Cell Ir
2026-07-15
FerroOrange is a validated Fe²⁺ fluorescent probe enabling real-time, live-cell intracellular iron detection with high specificity. Its robust performance supports advanced iron metabolism research and ferroptosis studies, as confirmed by both product and peer-reviewed evidence.
-
Structure-Based Discovery of NSP15 Inhibitors for SARS-CoV-2
2026-07-15
This article analyzes the structure-based virtual screening of natural products targeting the SARS-CoV-2 NSP15 endoribonuclease, highlighting the identification of thymopentin and oleuropein as promising inhibitors. The study's methodology and findings chart a path for anti-viral drug development focused on host immune evasion mechanisms.
-
CD28-ARS2 Axis Drives PKM Splicing and Metabolic Flexibility
2026-07-14
This study uncovers a novel CD28-ARS2 signaling pathway that controls alternative splicing of pyruvate kinase (PKM) in CD8+ T cells, enhancing their metabolic flexibility and antitumor function. These findings clarify how T cell costimulation reprograms glucose metabolism, offering new avenues for immunometabolism research.
-
Dual-Metric In Vitro Assays Refine Cancer Drug Response Anal
2026-07-14
Schwartz’s dissertation introduces a dual-metric framework distinguishing proliferative arrest from cell death in anti-cancer drug evaluation. This approach enhances the precision of in vitro assays and informs better translational strategies in cancer biology.
-
Nanoplastics and Cadmium Co-Exposure Drives Intestinal Apopt
2026-07-13
This study reveals that simultaneous exposure to polystyrene nanoplastics and cadmium induces apoptosis in intestinal cells through activation of the IP3R/Ca2+/STAT3 pathway. These findings provide mechanistic insight into how co-pollutant exposures amplify cellular toxicity, with practical implications for environmental toxicology research and calcium signaling modulation.
-
Tacrine Hydrochloride Hydrate: Optimizing Alzheimer’s Assays
2026-07-13
Tacrine hydrochloride hydrate (Tetrahydroaminacrine) is a benchmark tool for dissecting cholinergic mechanisms and multi-target neuroprotection in Alzheimer’s disease research. This guide brings together evidence-driven protocol enhancements, advanced troubleshooting, and practical insights to maximize reproducibility and translational value with APExBIO’s high-purity formulation.
-
Phytol Applications: RXR Signaling and Nanomaterial Innovati
2026-07-12
Phytol’s unique RXR activation properties and cross-talk with GABAergic and PPARα pathways make it a versatile tool for both cellular signaling studies and advanced polymer research. Learn how experimentalists can leverage its solubility, stability, and functional flexibility for robust results in cutting-edge workflows.
-
HyperFusion™ High-Fidelity DNA Polymerase: PCR Reliability i
2026-07-10
This article examines real-world challenges in PCR-based neurogenetic research, focusing on reproducibility, GC-rich templates, and assay reliability. Through scenario-driven Q&As, it demonstrates how HyperFusion™ high-fidelity DNA polymerase (SKU K1032) delivers robust, high-fidelity amplification, with practical recommendations grounded in quantitative data and peer-reviewed literature.
-
Phosphoproteomic Adaptation to Chronic Cabozantinib in RCC
2026-07-09
This study provides a systems-level analysis of timescale-dependent phosphoproteomic remodeling in renal cell carcinoma (RCC) cells exposed to cabozantinib (XL184). By integrating quantitative phosphoproteomics with functional motility assays, the research highlights sustained MET inhibition and distinct adhesion- and MAPK-pathway adaptations under chronic drug pressure.
-
Cholesterol as Principal Sterol in Lipid Nanoparticle Resear
2026-07-09
Cholesterol is indispensable as the principal sterol for engineering high-performance lipid nanoparticle systems in cutting-edge mRNA delivery, especially in cancer research. This article synthesizes advanced workflows, comparative advantages, and practical troubleshooting for maximizing cholesterol’s impact in experimental membrane and nanoparticle applications.